does glp 1 affect kidneys GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Glucagon-like peptide-1 receptor signaling modifies

Discover the research, how they work, who should try these, and more.

As weight-loss drug popularity soars, more benefits and risks of the drugs are emerging.

Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, announced today a major

Although the findings are encouraging, scientists say larger studies are needed before concluding that the medication can help people age more slowly.

It dissolves easily in waterand fits easily into your life.

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist increasingly prescribed for weight loss, is generally well tolerated but may have underrecognized gastrointestinal complications